Body weight-based natalizumab treatment in adult patients with multiple sclerosis

J Neurol. 2015 Mar;262(3):781-2. doi: 10.1007/s00415-015-7655-1. Epub 2015 Feb 7.

Authors

M Tanaka¹, M Kinoshita, J F Foley, K Tanaka, J Kira, W M Carroll

Affiliation

¹ Multiple Sclerosis Center, Utano National Hospital, 8 Ondoyama, Narutaki, Ukyo-ku, Kyoto, 616-8255, Japan, nra17777@nifty.com.

PMID: 25663410
DOI: 10.1007/s00415-015-7655-1

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Aged
Body Weight*
Female
Humans
Immunologic Factors / therapeutic use*
Male
Middle Aged
Multiple Sclerosis / drug therapy*
Natalizumab / therapeutic use*

Substances

Immunologic Factors
Natalizumab